We reported for the development and characterization of NASH by imaging and by histological steatosis evaluation in middle-aged Methods: Seventy e

1008: Naturally Occurring Hypertension is Related to Cardiac Diastolic Dysfunction in Rhesus Monkeys

1993-P: Adaptation of Slow- and Fast-twitch Skeletal Muscles to Type 2 Diabetes Mellitus (T2DM) in Diabetic Rhesus Monkeys: an Initial Experience with Non-contrast MRI Microcirculation Mapping Techniq

Diagnosis of Naturally-occurring Nonalcoholic Fatty Liver Disease (NAFLD) in Obese Rhesus Monkeys using dual-energy CT (DECT) and Histopathology Criteria

Nonalcoholic Fatty Liver Disease (NAFLD) in Obese Nonhuman Primates (NHP’s) is Comparable to Humans for Metabolic Features, Histology and Imaging

1663: A Novel FXR Agonist (HT03) for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Rhesus Monkeys1652: Pathological Study of Non-alcoholic Steatohepatitis (NASH) in Rhesus Monkeys

217-OR: Diffuse Myocardial Fibrosis Quantified by T1 Mapping at 3T Increases in Early Diabetic Cardiomyopathy: A Preclinical Validation Study in Nonhuman Primates.

Quantification Of Hepatic Fat In Naturally-occurring Nonalcoholic Fatty Liver Disease (NAFLD) In Obese Rhesus Monkeys Using Dual-energy CT (DECT)

1840-P: Blood-Brain Barrier Permeability Increased in Rhesus Monkeys with Spontaneous T2DM: A Non-Invasive MRI Study2122-P: Effects of a Long-Acting Formulation of Exenatide on Glucose and Weight Cont

266-LB: A Diabetic Monkey Model Can Be Used for Diabetes Therapy Evaluation